Sumitomo Mitsui Trust Group Inc. Has $22.45 Million Holdings in Solventum Corporation $SOLV

Sumitomo Mitsui Trust Group Inc. cut its position in shares of Solventum Corporation (NYSE:SOLV) by 7.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 295,970 shares of the company’s stock after selling 23,719 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned about 0.17% of Solventum worth $22,446,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Rossby Financial LCC acquired a new stake in shares of Solventum during the first quarter worth $25,000. Strengthening Families & Communities LLC increased its position in shares of Solventum by 376.8% during the first quarter. Strengthening Families & Communities LLC now owns 329 shares of the company’s stock worth $25,000 after buying an additional 260 shares during the period. Barrett & Company Inc. increased its position in shares of Solventum by 206.2% during the second quarter. Barrett & Company Inc. now owns 398 shares of the company’s stock worth $30,000 after buying an additional 268 shares during the period. IMG Wealth Management Inc. acquired a new stake in shares of Solventum during the second quarter worth $31,000. Finally, Hara Capital LLC acquired a new stake in Solventum in the first quarter worth $38,000.

Analysts Set New Price Targets

A number of equities research analysts have commented on SOLV shares. Piper Sandler restated an “overweight” rating and issued a $94.00 price target (up from $87.00) on shares of Solventum in a report on Friday, August 8th. Jefferies Financial Group started coverage on shares of Solventum in a report on Thursday, September 11th. They issued a “hold” rating and a $80.00 price target for the company. Wall Street Zen cut shares of Solventum from a “strong-buy” rating to a “buy” rating in a report on Tuesday, September 9th. Morgan Stanley upgraded shares of Solventum from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $80.00 to $103.00 in a report on Tuesday, July 15th. Finally, Zacks Research upgraded shares of Solventum from a “hold” rating to a “strong-buy” rating in a report on Monday, September 15th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $84.89.

Solventum Stock Down 1.3%

SOLV opened at $71.04 on Wednesday. The company has a debt-to-equity ratio of 2.14, a current ratio of 1.22 and a quick ratio of 0.86. The company’s 50-day moving average is $72.62 and its 200 day moving average is $72.28. Solventum Corporation has a fifty-two week low of $60.70 and a fifty-two week high of $85.92. The firm has a market capitalization of $12.32 billion, a P/E ratio of 32.89, a PEG ratio of 2.92 and a beta of 0.50.

Solventum (NYSE:SOLV) last announced its quarterly earnings data on Thursday, August 7th. The company reported $1.69 EPS for the quarter, topping the consensus estimate of $1.45 by $0.24. The business had revenue of $2.16 billion for the quarter, compared to analyst estimates of $2.12 billion. Solventum had a net margin of 4.52% and a return on equity of 29.93%. The company’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.56 earnings per share. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. Research analysts expect that Solventum Corporation will post 6.58 earnings per share for the current fiscal year.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.